Parabilis Medicines Inc (PBLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Parabilis Medicines Inc-Aktie (PBLS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30
Periodenlänge	3 Monate
Revenues
Operating Expenses
Depreciation and Amortization
Operating Income/Loss
Nonoperating Income/Loss
Net Income/Loss
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share

IDYA

$33.85

0.03%

CELC

$60.30

0.67%

DNLI

$18.34

2.63%

RCUS

$22.82

1.29%

TARS

$70.99

1.80%

XENE

$34.33

1.27%